Q13546 RIPK1


Group: TKL
Family: RIPK
PDB Structure Num: 11
FDA approved drugs from DrugBank: Fostamatinib






structure FDA kinase druginchikeydata countactive numinactive numsame percentagevote label
KNDPXYAMINMLED-UHFFFAOYSA-N330100%active
LSVIBAPJYUUVJJ-UHFFFAOYSA-N32166.67%exclude
OXFFBLXVJFWLLK-UHFFFAOYSA-N330100%active
GWTAOAWWDHYJKW-UHFFFAOYSA-N330100%active
CIUJFUBCFGKNHD-UHFFFAOYSA-N32166.67%exclude
IWNXEUPHZRHHNK-UHFFFAOYSA-N32166.67%exclude
WEPHZYIMARBFLD-UHFFFAOYSA-N32166.67%exclude
PPOHTLIVXPSOLN-UHFFFAOYSA-N32166.67%exclude
WEHLCQBCEXVDFL-UHFFFAOYSA-N32166.67%exclude
SLRYMOUSQMDJPH-UHFFFAOYSA-N53260%active
CUQNUTWHEMOZGU-UHFFFAOYSA-N330100%active
AMXYLFXYHCZHEV-UHFFFAOYSA-N330100%active
DCKXDFIWMOCNBS-UHFFFAOYSA-N330100%active
PUXQYEIQXOQBTI-UHFFFAOYSA-N330100%active
XHFYVNWXSOUNAK-UHFFFAOYSA-N330100%active
WEUBRKIFFZSMJY-UHFFFAOYSA-N303100%exclude
HQPGNAQSHLIGDV-UHFFFAOYSA-N330100%active
VNKUEEYDAKRQLH-UHFFFAOYSA-N330100%active
PVTFULWPKJRLFF-UHFFFAOYSA-N330100%active
QQTPMHCXBYRWFQ-UHFFFAOYSA-N330100%active
QFAPOWQTBPKCIL-UHFFFAOYSA-N330100%active
JSDJGQNZDVHBTJ-UHFFFAOYSA-N330100%active
STOIQAGAYIQTEP-UHFFFAOYSA-N31266.67%exclude
BASRWXZKOTYWGV-UHFFFAOYSA-N32166.67%exclude
FFELVARLIOWSSQ-UHFFFAOYSA-N32166.67%exclude
CNGLULHYIHCZMR-UHFFFAOYSA-N32166.67%exclude
WENIFNSHNVTKCT-UHFFFAOYSA-N330100%active
MIHYJIQBKUKKMZ-UHFFFAOYSA-N32166.67%exclude
SCAQPCRSYNOLDB-UHFFFAOYSA-N330100%active
VLTNUYNTYZRWQD-UHFFFAOYSA-N32166.67%exclude
UFWXSGVSQZKZTR-UHFFFAOYSA-N21150%exclude
HYHNNPKOTNCPJU-UHFFFAOYSA-N31266.67%exclude
IKUITEPQCFCQBL-UHFFFAOYSA-N303100%inactive
ZKOPOIXNUXDXMS-UHFFFAOYSA-N303100%inactive
BTAQQMMTAQWGCF-UHFFFAOYSA-N303100%inactive
WIKGAEMMNQTUGL-SNVBAGLBSA-N32166.67%exclude
KNOUWGGQMADIBV-KRWDZBQOSA-N440100%active
AWXYMMISTIIAIH-IBGZPJMESA-N330100%active
HMBAEAQKWTXBHE-KRWDZBQOSA-N660100%active
KSXXLKPPWYRQCT-HNNXBMFYSA-N21150%exclude
KXBWKWXLJDJUTG-KRWDZBQOSA-N330100%active
GCXSDJBPWVZLCU-KRWDZBQOSA-N110100%active
FILOHPAPJRJFDF-SFHVURJKSA-N330100%active
XLSNJTZNUHLDQC-SFHVURJKSA-N110100%active
ZMNTWFPENWVBQI-KRWDZBQOSA-N110100%active
SIDIZJFULUPVLJ-SFHVURJKSA-N110100%active
NIAHVVIUZUZDFS-KRWDZBQOSA-N110100%active
QIFUAERRNRWOHL-SFHVURJKSA-N330100%active
TXUWMXQFNYDOEZ-UHFFFAOYSA-N21150%exclude
AVYVHIKSFXVDBG-UHFFFAOYSA-N110100%active
WFVAIXPNICATFZ-NSHDSACASA-N101100%inactive
MGFSXSQOCMPBJP-HNNXBMFYSA-N220100%active
PCBOLQOPKUEBBQ-SFHVURJKSA-N202100%inactive
DSXDWWSCVQGTED-KRWDZBQOSA-N21150%exclude
LYPAFUINURXJSG-AWEZNQCLSA-N770100%active
ZAOHUZJRHLAEQB-INIZCTEOSA-N202100%inactive
BNFZELRXWKQQTE-AWEZNQCLSA-N202100%inactive
ULDZVSQOTVSBOS-INIZCTEOSA-N202100%inactive
DTHGKYMYOHZWJQ-KRWDZBQOSA-N21150%exclude
IEZROSAHMNRZNO-FQEVSTJZSA-N220100%active
LJJNVLRAHSNYBH-KRWDZBQOSA-N21150%exclude
BHGNGKHGBLRBON-INIZCTEOSA-N202100%inactive
YHGUHKWOKRNNEY-SFHVURJKSA-N220100%active
OJLFTGVMYJICFC-HNNXBMFYSA-N220100%active
MXFYWJGZIMCVJB-INIZCTEOSA-N220100%active
IIZWFTNGDCXXNB-IBGZPJMESA-N220100%active
NMALKWDSCYKLFE-KRWDZBQOSA-N220100%active
AEBVXDRUAUWPIF-SFHVURJKSA-N220100%active
BYZLFSSTPKOLGN-IBGZPJMESA-N220100%active
NLYLKUVVWLYFQA-INIZCTEOSA-N220100%active
PIWMULXWWGHQRV-SFHVURJKSA-N220100%active
UPZROLYOVJIAFN-AWEZNQCLSA-N220100%active
XSNVBMXTHDEJRZ-KRWDZBQOSA-N220100%active
SDSKXUMJPYXQBG-AWEZNQCLSA-N220100%active
NABLDJAKXWEMDU-SFHVURJKSA-N220100%active
JYJCMYZVWUPJEP-AWEZNQCLSA-N220100%active
QPQWAUBXMFKFMA-FQEVSTJZSA-N220100%active
JWKONLKXWPCOJF-IBGZPJMESA-N110100%active
WIKGAEMMNQTUGL-UHFFFAOYSA-N101100%inactive
JSKOFTDOVDUJQY-UHFFFAOYSA-N101100%inactive
JNZKENWWCGIHDV-UHFFFAOYSA-N110100%active
KDCYOEAWXNGQEB-UHFFFAOYSA-N110100%active
FXGOMJXGESCWPD-UHFFFAOYSA-N110100%active
HMBAEAQKWTXBHE-QGZVFWFLSA-N404100%inactive
SVDBBRBKNKIPIZ-AWEZNQCLSA-N202100%inactive
HRABCZBNSJGFHF-OAHLLOKOSA-N202100%inactive
KBCHZCAGZMGNKY-NRFANRHFSA-N202100%inactive
BSCAWJZUMKSTPZ-UHFFFAOYSA-N202100%inactive
NWRTYCXBUOHPGL-IBGZPJMESA-N202100%inactive
KSFRDMSRIFRFHD-BPQIPLTHSA-N101100%inactive
ZDSBJQYOCAGAGG-INIZCTEOSA-N202100%inactive
RRKCMOVROKRSEM-SFHVURJKSA-N202100%inactive